Join to access to all OVN content. Join for Free
Why Go ALONE? How 2 Aspiring MSLs Reached Their Goal TOGETHER
MSL roles collaboration strategies job search tactics aspiring MSLs mentorship importance

Why Go ALONE? How 2 Aspiring MSLs Reached Their Goal TOGETHER


Share This Article


Summary

In this episode, Tom Caravela is joined by Sierra Birch and George Lehman to discuss the power of collaboration in securing MSL roles. Celebrating a milestone of nearly 250,000 listeners, the episode explores Sierra and George's professional journeys and their organic partnership. They share strategies and beneficial practices for landing MSL positions, while also addressing challenges and ineffective approaches. The conversation highlights the importance of mentors and outlines key requirements for aspiring MSLs. Concluding with a speed round of advice, the episode offers encouragement and appreciation for the audience.

My guests are George Limen, Medical Liaison at Novo Nordisk and Cierra Birch, Molecular Science Liaison with Caris Life Science and discuss how they collaborated to land their first MSL positions
We discuss….

πŸ‘‰ How they joined forces to find success in their job searches
πŸ‘‰ What were some of the most impactful tactics in the process
πŸ‘‰ What challenges they faced along the way
πŸ‘‰ How they dealt with frustration and discouragement
πŸ‘‰ What were the absolute MUSTs for these efforts

Click for Source
MSL roles, collaboration strategies, job search tactics, aspiring MSLs, mentorship importance

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
No β€œD”…No Problem: Finding Success WITHOUT a Doctorate
Partner Avatar MSL Talk: Tom Caravela, Greg Auclair

No β€œD”…No Problem: Finding Success WITHOUT a Doctorate

Podcast
Role of the MSL in launch preparedness for new products and indications
Partner Avatar MSL Talk: Tom Caravela, Matt Goodwin

Role of the MSL in launch preparedness for new products and indications

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, GaΓ«lle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN